FDA OKs Accurian Nerve Ablation Platform for Chronic Pain

The minimally invasive ablative procedure destroys small areas of nerve tissue to stop it from sending pain signals, thereby reducing pain, Medtronic says.
Medscape Medical News

Source link

Related posts

Time-of-day influence on the stability Evaluation Test in college-age women


Electrically induced verbal perseveration: A striatal deafferentation model


Brain SPECT Imaging Predicts Outcomes in Depressed Patients


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy